News-Medical.Net on MSN

Reprogramming immunity to protect beta cells in type 1 diabetes

In the battle against type 1 diabetes (T1D), one researcher at the Medical University of South Carolina (MUSC) is leading a ...
Hosted on MSN

Lifechanging new diabetes drug increases insulin-production by 700%

A team of researchers has made a breakthrough in diabetes treatment, uncovering a way to regenerate human insulin-producing beta cells. Their discovery, published in Science Translational Medicine, ...
Morningstar

Icovamenib Treatment in Patients with Severe Insulin-Deficient Diabetes Led to a Significant Improvement in Pancreatic Beta-cell Function with a 53% Mean Increase in C-peptide ...

Therapeutic effects were sustained off treatment, with persistent reduction in HbA1c and improvement in beta-cell function 3 months after last dose, suggesting disease-modifying potential of ...
Nasdaq

Biomea Fusion Presents Promising Clinical Data on Icovamenib at ATTD 2025, Highlighting Its Potential as a Disease-Modifying Therapy for Type 2 Diabetes

Biomea Fusion, Inc. has presented promising clinical results for icovamenib, a novel therapy aimed at restoring beta-cell function in patients with type 2 diabetes, at the ATTD 2025 Conference.